PHIO Q2 2024 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$866,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-3.62

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$15,000

Balance Sheet

Total Assets

$5M

Total Liabilities

$2M

Stockholders' Equity

$4M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$866,000	-$49,000	-1667.3%
Operating Income	-$2M	-$3M	+24.9%
Net Income	-$2M	-$3M	+27.6%